Disparities in osteoporosis care after fragility fracture: a systematic review and meta-analysis
Authors' conclusion
Men and Black patients were significantly less likely to receive osteoporosis pharmacotherapy and bone density testing after fragility fracture.
Study context
- Population
- Adults with fragility fractures; studies reporting sex- or race-stratified data on post-fracture osteoporosis pharmacotherapy, DXA testing or referral80 studies
- Comparison
- Men vs women; Black vs White patients
- Outcome
- Initiation of osteoporosis pharmacotherapy, DXA testing and referral for osteoporosis evaluation after fragility fracture, stratified by sex and race
Methodological detailsData independently extracted by four authors, PubMed, CINAHL, Embase, Web of Science and Cochrane Library searched from inception through June 30, 2026
- Data independently extracted by four authors
- PubMed, CINAHL, Embase, Web of Science and Cochrane Library searched from inception through June 30, 2026
Pooled result
As reported in the abstract
Post-fracture osteoporosis care
Estimate (95% CI)
Menvs Women
pooled OR (osteoporosis pharmacotherapy) 0.43(0.36–0.50)
Menvs Women
OR (DXA testing) 0.39(0.31–0.50)
Blackvs White
OR (osteoporosis pharmacotherapy) 0.63(0.56–0.70)
Blackvs White
OR (DXA testing) 0.56(0.50–0.62)
Original publication
Disparities in osteoporosis care after fragility fracture: a systematic review and meta-analysis. Endocr Pract. Published 18 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →